COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Kimm Hamann

Dr. Kimm Hamann

Scientific Review Officer


Division of Translational and Clinical Sciences DTCS
Cardiovascular and Respiratory Sciences CVRS
Study Section:
Fellowships: Physiology and Pathobiology of Cardiovascular and Respiratory Systems F10A

Dr. Kimm Hamann serves as the Scientific Review Officer for CSR’s Myocardial Ischemia and Metabolism (MIM) Study Section.

After receiving his M.S. and Ph.D. from the University of Minnesota in ornithology and parasite immunology, respectively, he trained at the Mayo Clinic as a research fellow and research associate. In Mayo’s Department of Immunology, Dr. Hamann’s research focused on the molecular biology of the eosinophil. Before coming to NIH, Dr. Hamann spent more than 21 years at the University of Chicago as an NIH-funded principal investigator studying the role of eosinophils and other immune cells in respiratory diseases and later, the mechanisms underlying cell death in cardiovascular diseases. He also served as a regular member of MIM from 2004 to 2008. At the University, Dr. Hamann taught undergraduate and graduate level courses on animal models of human diseases and on cell injury and repair, and he served as the Director of Basic Sciences for the University’s Emergency Resuscitation Center.